Screening compound: XLOMAHIVNRSLCU-ZKMANVEGSA-N

Screening compound: XLOMAHIVNRSLCU-ZKMANVEGSA-N
Screening compound: XLOMAHIVNRSLCU-ZKMANVEGSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
XLOMAHIVNRSLCU-ZKMANVEGSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K935-0031

Molecular Formula

C37H42N2O4 (C37 H42 N2 O4)

Compound Name

2-oxo-2-[4-(4-propylcyclohexyl)phenyl]ethyl 2-[(4-ethylphenyl)formamido]-3-(1H-indol-3-yl)propanoate

IUPAC name

2-oxo-2-[4-(4-propylcyclohexyl)phenyl]ethyl 2-[(4-ethylphenyl)formamido]-3-(1H-indol-3-yl)propanoate

SMILES

CCCC(CC1)CCC1c(cc1)ccc1C(COC(C(Cc1c[nH]c2c1cccc2)NC(c1ccc(CC)cc1)=O)=O)=O

InChI

InChI=1S/C37H42N2O4/c1-3-7-26-12-14-27(15-13-26)28-18-20-29(21-19-28)35(40)24-43-37(42)34(22-31-23-38-33-9-6-5-8-32(31)33)39-36(41)30-16-10-25(4-2)11-17-30/h5-6,8-11,16-21,23,26-27,34,38H,3-4,7,12-15,22,24H2,1-2H3,(H,39,41)/t26?,27?,34-/m0/s1

InChI Key

XLOMAHIVNRSLCU-ZKMANVEGSA-N

MDL Number (MFCD)

MFCD06663597

XLOMAHIVNRSLCU-ZKMANVEGSA-N in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Eccentric PPI Library (11937 compounds)

Lipid Metabolism Library (9174 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Antibacterial Compounds Library (13827 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cardiovascular
  • Metabolic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Infections
  • Immune system
  • animal
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Cyclic compounds
Targets:
  • Proteases
  • Phosphatases

References: we are preparing a list of scientific research reports with XLOMAHIVNRSLCU-ZKMANVEGSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound XLOMAHIVNRSLCU-ZKMANVEGSA-N?
Check Price and Availability of XLOMAHIVNRSLCU-ZKMANVEGSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of XLOMAHIVNRSLCU-ZKMANVEGSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for XLOMAHIVNRSLCU-ZKMANVEGSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for XLOMAHIVNRSLCU-ZKMANVEGSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of XLOMAHIVNRSLCU-ZKMANVEGSA-N available by request